ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update

Go back to ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: NDRA) Delayed: 4.86 -0.37 (7.07%)
Previous Close $5.23    52 Week High
Open $5.11    52 Week Low
Day High $5.19    P/E N/A 
Day Low $4.86    EPS
Volume 7,655